why choose us

First received: June 09, 2023

Clinical Trial: Safety, Tolerability and Pharmacokinetics of L608 in Healthy Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Pulmonary Arterial Hypertension

Study Type: INTERVENTIONAL


Official Title: A Phase I, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of L608 for Inhalation in Healthy Subjects

Brief Summary: This is a Phase I, randomized, double-blinded, placebo-controlled single ascending dose, sequential-group study to evaluate the safety, tolerability, and PK of single ascending doses of L608 inhalation in healthy volunteers.

Read more